210 related articles for article (PubMed ID: 20157729)
1. Lymphocyte transformation test detects a response to Campylobacter jejuni antigens in patients with Guillain-Barré syndrome.
Nyati KK; Prasad KN; Rizwan A; Verma A; Paliwal VK; Pradhan S
Med Microbiol Immunol; 2010 May; 199(2):109-16. PubMed ID: 20157729
[TBL] [Abstract][Full Text] [Related]
2. Detection of preceding Campylobacter jejuni infection by polymerase chain reaction in patients with Guillain-Barré syndrome.
Sinha S; Prasad KN; Pradhan S; Jain D; Jha S
Trans R Soc Trop Med Hyg; 2004 Jun; 98(6):342-6. PubMed ID: 15099989
[TBL] [Abstract][Full Text] [Related]
3. Transplanted human fecal microbiota enhanced Guillain Barré syndrome autoantibody responses after Campylobacter jejuni infection in C57BL/6 mice.
Brooks PT; Brakel KA; Bell JA; Bejcek CE; Gilpin T; Brudvig JM; Mansfield LS
Microbiome; 2017 Aug; 5(1):92. PubMed ID: 28789710
[TBL] [Abstract][Full Text] [Related]
4. Role of Campylobacter jejuni infection in the pathogenesis of Guillain-Barré syndrome: an update.
Nyati KK; Nyati R
Biomed Res Int; 2013; 2013():852195. PubMed ID: 24000328
[TBL] [Abstract][Full Text] [Related]
5. Innate Immunity to Campylobacter jejuni in Guillain-Barré Syndrome.
Huizinga R; van den Berg B; van Rijs W; Tio-Gillen AP; Fokkink WJ; Bakker-Jonges LE; Geleijns K; Samsom JN; van Doorn PA; Laman JD; Jacobs BC
Ann Neurol; 2015 Sep; 78(3):343-54. PubMed ID: 26017721
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barré syndrome with preceding Campylobacter jejuni and other identified infections.
Hao Q; Saida T; Kuroki S; Nishimura M; Nukina M; Obayashi H; Saida K
J Neuroimmunol; 1998 Jan; 81(1-2):116-26. PubMed ID: 9521613
[TBL] [Abstract][Full Text] [Related]
7. Improved serological diagnosis stresses the major role of Campylobacter jejuni in triggering Guillain-Barré syndrome.
Schmidt-Ott R; Schmidt H; Feldmann S; Brass F; Krone B; Gross U
Clin Vaccine Immunol; 2006 Jul; 13(7):779-83. PubMed ID: 16829615
[TBL] [Abstract][Full Text] [Related]
8. Guillain-Barré syndrome subtypes related to Campylobacter infection.
Drenthen J; Yuki N; Meulstee J; Maathuis EM; van Doorn PA; Visser GH; Blok JH; Jacobs BC
J Neurol Neurosurg Psychiatry; 2011 Mar; 82(3):300-5. PubMed ID: 21270063
[TBL] [Abstract][Full Text] [Related]
9. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.
Koga M; Takahashi M; Masuda M; Hirata K; Yuki N
Neurology; 2005 Nov; 65(9):1376-81. PubMed ID: 16162859
[TBL] [Abstract][Full Text] [Related]
10. Association study between an outbreak of Guillain-Barre syndrome in Jilin, China, and preceding Campylobacter jejuni infection.
Zhang M; Li Q; He L; Meng F; Gu Y; Zheng M; Gong Y; Wang P; Ruan F; Zhou L; Wu J; Chen L; Fitzgerald C; Zhang J
Foodborne Pathog Dis; 2010 Aug; 7(8):913-9. PubMed ID: 20455754
[TBL] [Abstract][Full Text] [Related]
11. Co-infection with two different Campylobacter jejuni strains in a patient with the Guillain-Barré syndrome.
Godschalk PC; Gilbert M; Jacobs BC; Kramers T; Tio-Gillen AP; Ang CW; Van den Braak N; Li J; Verbrugh HA; Van Belkum A; Endtz HP
Microbes Infect; 2006 Jan; 8(1):248-53. PubMed ID: 16213180
[TBL] [Abstract][Full Text] [Related]
12. Detection of Campylobacter jejuni by culture and real-time PCR in a French cohort of patients with Guillain-Barre syndrome.
Sivadon-Tardy V; Orlikowski D; Porcher R; Ronco E; Caudie C; Roussi J; Fauchère JL; Mégraud F; Tabor H; Sharshar T; Annane D; Raphaël JC; Gaillard JL
J Clin Microbiol; 2010 Jun; 48(6):2278-81. PubMed ID: 20410350
[TBL] [Abstract][Full Text] [Related]
13. Campylobacter jejuni infection in Guillain-Barré syndrome: a prospective case control study in a tertiary care hospital.
Sharma A; Lal V; Modi M; Vaishnavi C; Prabhakar S
Neurol India; 2011; 59(5):717-21. PubMed ID: 22019657
[TBL] [Abstract][Full Text] [Related]
14. Relationship between pathogenesis of Guillain-Barre syndrome and Penner's serotypes of Campylobacter jejuni.
Li H; Yuan J; Shen B; Sun X; Hao H
Chin Med J (Engl); 1999 Sep; 112(9):794-6. PubMed ID: 11717947
[TBL] [Abstract][Full Text] [Related]
15. TLR4-mediated sensing of Campylobacter jejuni by dendritic cells is determined by sialylation.
Kuijf ML; Samsom JN; van Rijs W; Bax M; Huizinga R; Heikema AP; van Doorn PA; van Belkum A; van Kooyk Y; Burgers PC; Luider TM; Endtz HP; Nieuwenhuis EE; Jacobs BC
J Immunol; 2010 Jul; 185(1):748-55. PubMed ID: 20525894
[TBL] [Abstract][Full Text] [Related]
16. TH1 and TH2 response to Campylobacter jejuni antigen in Guillain-Barre syndrome.
Nyati KK; Prasad KN; Rizwan A; Verma A; Paliwal VK
Arch Neurol; 2011 Apr; 68(4):445-52. PubMed ID: 21482924
[TBL] [Abstract][Full Text] [Related]
17. The demyelination neurophysiological criteria can be misleading in Campylobacter jejuni-related Guillain-Barré syndrome.
Kokubun N; Shahrizaila N; Koga M; Hirata K; Yuki N
Clin Neurophysiol; 2013 Aug; 124(8):1671-9. PubMed ID: 23514735
[TBL] [Abstract][Full Text] [Related]
18. Association between Campylobacter infection and Guillain-Barré syndrome.
Allos BM
J Infect Dis; 1997 Dec; 176 Suppl 2():S125-8. PubMed ID: 9396695
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of Campylobacter jejuni isolated from patients with Guillain-Barré and Fisher syndromes in Japan.
Takahashi M; Koga M; Yokoyama K; Yuki N
J Clin Microbiol; 2005 Jan; 43(1):335-9. PubMed ID: 15634991
[TBL] [Abstract][Full Text] [Related]
20. Utility of serum Campylobacter specific antibodies in determining prior Campylobacter infection in neurological disease.
Taylor BV; Williamson J; Jones D; Coleman D; Luck J; McGregor A
J Clin Neurosci; 2007 Feb; 14(2):116-21. PubMed ID: 17107803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
